Alemtuzumab-induced halo naevus-like hypopigmentation - new insights into secondary skin autoimmunity in response to an immune cell-depleting antibody.

Böhm, M; Kemp, E H; Metze, D; Muresan, A M; Neufeld, M; Luiten, R M; Ruck, T

Böhm, M; Kemp, E H; Metze, D; Muresan, A M; Neufeld, M; Luiten, R M; Ruck, T.

Afiliación

Böhm M; Department of Dermatology, University of Münster, Münster, Germany.
Kemp EH; Department of Oncology and Metabolism, University of Sheffield, Sheffield, UK.
Metze D; Department of Dermatology, University of Münster, Münster, Germany.
Muresan AM; Department of Dermatology, University of Münster, Münster, Germany.
Neufeld M; Department of Dermatology, University of Münster, Münster, Germany.
Luiten RM; Department of Dermatology and Netherlands Institute for Pigment Disorders, Amsterdam UMC, Amsterdam Institute for Infection and Immunity, University of Amsterdam, Amsterdam, The Netherlands.
Ruck T; Clinic of Neurology with Institute for Translational Neurology, University of Münster, Münster, Germany.

J Eur Acad Dermatol Venereol ; 35(1): e28-e30, 2021 Jan.

Article en En | MEDLINE | ID: mdl-32579750

Asunto(s)

Alemtuzumab; Hipopigmentación; Nevo con Halo; Neoplasias Cutáneas; Alemtuzumab/efectos adversos; Autoinmunidad; Humanos; Hipopigmentación/inducido químicamente

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Cutáneas / Hipopigmentación / Nevo con Halo / Alemtuzumab Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2021 Tipo del documento: Article País de afiliación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google